ICUI

SEC source: 0001073397-19-000002 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,864

F1 · price: Shares transferred as a bona fide gift without any consideration.

SEC source: 0001615192-18-000014 · edgardoc.xml · derivative · entry 3

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 223 shares

Expires 2018-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001615192-18-000014 · edgardoc.xml · nonDerivative · entry 2

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001615192-18-000014 · edgardoc.xml · nonDerivative · entry 1

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,515

SEC source: 0000078003-18-000095 · primary_doc.xml · nonDerivative · entry 1

PFIZER INC · CIK 0000078003 · Director

C.P. Pharmaceuticals International C.V. · CIK 0001697389 · See Note (1)

Pfizer Production LLC · CIK 0001697379 · See Note (1)

Pfizer Manufacturing LLC · CIK 0001697471 · See Note (1)

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · -

Disclosed balance after: 0

F1 · balance_after: These shares were owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM were indirect beneficial owners of the shares, but each of PPL and PML, as a general partner of CPPI, disclaims ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

F1 · ownership.direct: These shares were owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM were indirect beneficial owners of the shares, but each of PPL and PML, as a general partner of CPPI, disclaims ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

F1 · ownership.nature: These shares were owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM were indirect beneficial owners of the shares, but each of PPL and PML, as a general partner of CPPI, disclaims ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

SEC source: 0001615192-18-000012 · edgardoc.xml · derivative · entry 3

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,143

Underlying: Common Stock · 571 shares

Expires 2020-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001615192-18-000012 · edgardoc.xml · nonDerivative · entry 2

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,626

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001615192-18-000012 · edgardoc.xml · nonDerivative · entry 1

McGrody Kevin J · CIK 0001615192 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,055

SEC source: 0001669639-18-000010 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,367

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001615186-18-000008 · edgardoc.xml · derivative · entry 13

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,392 shares

Expires 2025-02-11

F5 · derivative.exercise_date: Options exercisable one-third annually over the first three anniversaries of the grant date.

SEC source: 0001615186-18-000008 · edgardoc.xml · derivative · entry 10

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,142 shares

Expires 2024-02-24

F4 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 8

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,191

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.38 to $303.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 7

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,092

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.35 to $303.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 6

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,725

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 5

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,583

SEC source: 0001669639-18-000008 · edgardoc.xml · derivative · entry 3

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,049 shares

Expires 2018-08-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001669639-18-000008 · edgardoc.xml · nonDerivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,154

SEC source: 0001669639-18-000008 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001615186-18-000008 · edgardoc.xml · derivative · entry 12

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 563 shares

Expires 2023-02-06

F4 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001615186-18-000008 · edgardoc.xml · derivative · entry 11

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 209 shares

Expires 2022-10-11

F4 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001615186-18-000008 · edgardoc.xml · derivative · entry 9

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,142

Underlying: Common Stock · 827 shares

Expires 2024-02-24

F4 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 4

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,191

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 3

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,982

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 2

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419

F1 · price: The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $301.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001615186-18-000008 · edgardoc.xml · nonDerivative · entry 1

McCall Thomas D · CIK 0001615186 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,018

SEC source: 0000078003-18-000075 · primary_doc.xml · nonDerivative · entry 1

PFIZER INC · CIK 0000078003 · Director · 10% owner

C.P. Pharmaceuticals International C.V. · CIK 0001697389 · 10% owner

Pfizer Production LLC · CIK 0001697379 · 10% owner

Pfizer Manufacturing LLC · CIK 0001697471 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · _

Disclosed balance after: 2,500,000

F1 · balance_after: These shares are owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM are indirect beneficial owners of the shares, but each of PPL and PML, as a general partner of CPPI, disclaims ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

F1 · ownership.direct: These shares are owned directly by C.P. Pharmaceuticals International C.V. ("CPPI"), whose general partners are Pfizer Production LLC ("PPL") and Pfizer Manufacturing LLC ("PPM"). CPPI, PPL and PPM are indirect wholly-owned subsidiaries of Pfizer Inc. ("Pfizer"). Pfizer, PPL and PPM are indirect beneficial owners of the shares, but each of PPL and PML, as a general partner of CPPI, disclaims ownership of securities held by CPPI except to the extent of any pecuniary interest therein.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,648

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.20 to 291.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 364,357

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $289.15 to 290.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 367,680

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $288.10 to 289.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000016 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 372,497

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $287.05 to 288.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 8

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,444

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F9 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.08 to 292.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 7

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,310

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F8 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.05 to 292.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 6

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 376,905

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F7 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.00 to 290.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 5

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,953

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F6 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $288.95 to 289.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 4

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 379,853

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $293.35 to 293.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 3

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 380,159

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $292.15 to 293.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 2

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,110

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $291.10 to 292.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001073397-18-000014 · edgardoc.xml · nonDerivative · entry 1

LOPEZ GEORGE A · CIK 0001073397 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 387,875

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.05 to 291.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000012 · edgardoc.xml · derivative · entry 9

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,219 shares

Expires 2025-02-11

F7 · price: Transaction is the exercise of a derivative security; see Column 2.

F8 · derivative.exercise_date: Options exercisable one-third annually over the first three anniversaries of the grant date.

SEC source: 0001189727-18-000012 · edgardoc.xml · derivative · entry 8

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,976 shares

Expires 2024-02-24

F7 · price: Transaction is the exercise of a derivative security; see Column 2.

F6 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 7

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 6

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 257

F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $297.95 to $298.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 5

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,669

F3 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.85 to $297.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 4

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,171

F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.80 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 3

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,875

F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 2

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,195

SEC source: 0001189727-18-000012 · edgardoc.xml · nonDerivative · entry 1

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,219

SEC source: 0001189727-18-000010 · edgardoc.xml · derivative · entry 21

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Common Stock · 21,169 shares

Expires 2024-02-24

F17 · price: Transaction is the exercise of a derivative security; see Column 2.

F16 · derivative.exercise_date: Options exercisable in four equal annual cumulative installments commencing one year after the grant date.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 18

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F5 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001189727-18-000010 · edgardoc.xml · nonDerivative · entry 17

BURCAR ALISON D · CIK 0001189727 · Vice President and Gen'l Mgr.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,125

F15 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.30 to $302.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.